Choosing the right treatment for tobacco dependence increases the chance of success. We aimed to determine the independent variables that may predict the success of smoking cessation in patients receiving pharmacotherapy other than nicotine replacement therapy (NRT) and to compare the effectiveness/side effects of treatments. The sample comprised 466 adult patients admitted to our smoking cessation clinic between 2015 and 2019, who started non-NRT treatment, and whose results were known and compatible with the treatment. Logistic regression analysis (Hosmer–Lemeshow test p=0.52) demonstrated the independent variables that reduce the success of smoking cessation: a Fagerström nicotine addiction test score above 8 (p=0.001, OR=1.9, CI=1.29-2.90), negative properties (depressive complaints and reluctance to quit smoking; p=0.009, OR=2.2, CI=1.21-3.99), and a short smoking period (p=0.006, OR=0.97, CI=0.95-0.99). Varenicline and Bupropion treatments were not superior to each other, and their side effects were similar. This study, to determine the group wherein the success of smoking cessation was low, provides insights into topics for further research to increase the chance of success.
Alan : Eğitim Bilimleri; Hukuk; Sağlık Bilimleri; Sosyal, Beşeri ve İdari Bilimler
Dergi Türü : Uluslararası
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|